Benzinga

Benzinga

Benzinga

domingo, septiembre 06

National Health Investors Inc

NHINYSE
Trade with Public
Trade with Public
$70.88
-1.03-1.43%
al cierre: Sep 4, 5:00 PM EST
$70.88
N/A
After hour: Sep 4, 4:00 PM EST
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadDividendosCompararOpcionesInforme de acciones

National Health Investors Analyst Price Targets

Wall Street analyst price targets and consensus rating for National Health Investors (NHI).

Price Target Range — 13 Quarters

Analyst Consensus — 10 Analysts

6Buy
4Hold
Consensus RatingOverweight# Analysts10Avg. Consensus PT$75Upside to Avg. PT+6.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Sep 2, 2026Truist SecuritiesMichael LewisPT CutBuy$81→$80
Sep 1, 2026Wells FargoJohn KilichowskiPT CutEqual-Weight$79→$78
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $80

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $81 to $80.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $78

Wells Fargo analyst John Kilichowski maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $79 to $78.
Benzinga Newsdesk

PRO
Deutsche Bank Maintains Hold on National Health Investors, Lowers Price Target to $80

Deutsche Bank analyst Omotayo Okusanya maintains National Health Investors (NYSE:NHI) with a Hold and lowers the price target from $85 to $80.
Benzinga Newsdesk

PRO
BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80

BMO Capital analyst Juan Sanabria maintains National Health Investors (NYSE:NHI) with a Outperform and lowers the price target from $90 to $80.
Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on National Health Investors, Lowers Price Target to $81

Truist Securities analyst Michael Lewis maintains National Health Investors (NYSE:NHI) with a Buy and lowers the price target from $89 to $81.
Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on National Health Investors, Lowers Price Target to $79

Wells Fargo analyst John Kilichowski maintains National Health Investors (NYSE:NHI) with a Equal-Weight and lowers the price target from $84 to $79.
Benzinga Newsdesk

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Datos de mercado proporcionados por APIs de Benzinga

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved